(BPT) - When a woman receives a breast cancer diagnosis, the journey ahead can feel overwhelming. Breast cancer affects one in eight women in their lifetime, and while treatment options have advanced significantly in recent years, not all women have benefited equally. According to a 2024 report on health care, women of different racial and ethnic backgrounds may experience varying health outcomes based on their unique biology and individual circumstances. For breast cancer specifically, research shows different mortality rates across population groups, with some experiencing higher rates than others despite similar or lower rates of cancer incidence. These variations highlight why personalized approaches that recognize each woman's unique biology are so important in breast cancer care.

As personalized medicine continues to evolve, genomic testing and inclusive research are playing a key role in ensuring that all women receive care that reflects the unique biology of their cancer. By supporting more informed, individualized treatment decisions, these tools are helping close gaps in care and improve outcomes for patients of every background, toward a future where every woman receives the care that is most appropriate for her unique diagnosis.

Recommended for you